These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 12415797)
21. Perspectives in the clinical management of BRCA mutations carriers. Savarese A; Cognetti F J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):31-5. PubMed ID: 12585651 [TBL] [Abstract][Full Text] [Related]
22. The impact of proband mediated information dissemination in families with a BRCA1/2 gene mutation. Sermijn E; Goelen G; Teugels E; Kaufman L; Bonduelle M; Neyns B; Poppe B; De Paepe A; De Grève J J Med Genet; 2004 Mar; 41(3):e23. PubMed ID: 14985394 [No Abstract] [Full Text] [Related]
24. Therapeutic approaches for women predisposed to breast cancer. Nathanson KL; Domchek SM Annu Rev Med; 2011; 62():295-306. PubMed ID: 21034216 [TBL] [Abstract][Full Text] [Related]
25. Reproductive issues for women with BRCA mutations. Friedman LC; Kramer RM J Natl Cancer Inst Monogr; 2005; (34):83-6. PubMed ID: 15784831 [TBL] [Abstract][Full Text] [Related]
26. Hereditary breast and ovarian cancer (HBOC): clinical features and counseling for BRCA1 and BRCA2, Lynch syndrome, Cowden syndrome, and Li-Fraumeni syndrome. Shulman LP Obstet Gynecol Clin North Am; 2010 Mar; 37(1):109-33, Table of Contents. PubMed ID: 20494261 [TBL] [Abstract][Full Text] [Related]
28. Hereditary breast and ovarian cancer syndrome. ACOG Committee on Practice Bulletins Gynecol Oncol; 2009 Apr; 113(1):6-11. PubMed ID: 19309638 [No Abstract] [Full Text] [Related]
29. Using genetic analysis to individualize preventive measures for breast and ovarian cancers. Olopade OI Nat Clin Pract Oncol; 2006 Apr; 3(4):182-3. PubMed ID: 16596140 [No Abstract] [Full Text] [Related]
30. The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain. Milne RL; Osorio A; Cajal TR; Vega A; Llort G; de la Hoya M; Díez O; Alonso MC; Lazaro C; Blanco I; Sánchez-de-Abajo A; Caldés T; Blanco A; Graña B; Durán M; Velasco E; Chirivella I; Cardeñosa EE; Tejada MI; Beristain E; Miramar MD; Calvo MT; Martínez E; Guillén C; Salazar R; San Román C; Antoniou AC; Urioste M; Benítez J Clin Cancer Res; 2008 May; 14(9):2861-9. PubMed ID: 18451254 [TBL] [Abstract][Full Text] [Related]
31. High-risk women should have BRCA testing. Cancer Discov; 2014 Feb; 4(2):139. PubMed ID: 24501290 [TBL] [Abstract][Full Text] [Related]
32. Concomitant BRCA1 and BRCA2 gene mutations in an Ashkenazi Jewish woman with primary breast and ovarian cancer. Spannuth WA; Thaker PH; Sood AK Am J Obstet Gynecol; 2007 Apr; 196(4):e6-9. PubMed ID: 17403394 [TBL] [Abstract][Full Text] [Related]
33. Re: "Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations". Olivier RI; van Beurden M Gynecol Oncol; 2005 Nov; 99(2):520-1. PubMed ID: 16188301 [No Abstract] [Full Text] [Related]
34. The identification and management of hereditary breast and ovarian cancer. Scalia JL; Legare RD Med Health R I; 2003 Feb; 86(2):48-51. PubMed ID: 12666278 [No Abstract] [Full Text] [Related]
35. Uptake of risk-reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age, and time dependent. Evans DG; Lalloo F; Ashcroft L; Shenton A; Clancy T; Baildam AD; Brain A; Hopwood P; Howell A Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2318-24. PubMed ID: 19661091 [TBL] [Abstract][Full Text] [Related]
36. Oophorectomy can reduce ovarian cancer risk in women with BRCA mutations: patients benefit from counseling, support. Printz C Cancer; 2013 Nov; 119(22):3897-8. PubMed ID: 24590900 [No Abstract] [Full Text] [Related]
37. [Genetic predisposition for breast cancer: BRCA1 and BRCA2 genes]. Narod SA; Rodríguez AA Salud Publica Mex; 2011; 53(5):420-9. PubMed ID: 22218796 [TBL] [Abstract][Full Text] [Related]
38. Women with family breast cancer history have no increased risk of ovarian cancer. Health News; 2006 Feb; 12(2):9. PubMed ID: 16456923 [No Abstract] [Full Text] [Related]
39. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations. Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145 [TBL] [Abstract][Full Text] [Related]
40. Prevention and management of hereditary breast cancer. Narod SA; Offit K J Clin Oncol; 2005 Mar; 23(8):1656-63. PubMed ID: 15755973 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]